Project Grant 201033610209361

This $389,782 Cooperative Agreement award from the United States Department of Agriculture's Animal and Plant Health Inspection Service (APHIS), under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), aims to develop highly specific and validated TaqMan assays for the simultaneous detection of two critical shrimp diseases: Hepatopancreatic Microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) and Acute Hepatopancreatic Necrosis Disease (AHPND) caused...

Federal Cooperative Agreement Summary The University of Florida received a $499,367 Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), effective September 1, 2025 through August 31, 2027. The project aims to develop and validate a multiplex assay utilizing nanopore sequencing technology to detect six economically significant shrimp pathogens...

This Project Grant award from the National Institute of Allergy and Infectious Diseases supports the development of a novel plant-based source for squalene as a natural vaccine adjuvant. The $514,006 award to Synshark LLC supports research to engineer tobacco plants to stably produce and accumulate squalene on their leaves. This work directly relates to the commercialization plan to provide a non-animal, indoor grown natural adjuvant for vaccines. Currently, squalene used in vaccines is...

This Project Grant from the National Oceanic and Atmospheric Administration's Small Business Innovation Research Program totaling $150,000 will support the development of rapid diagnostic tests for the parasitic infection Amyloodinium ocellatum in fish. Live Advantage Bait, LLC dba Totally Pelagic will utilize next generation approaches to produce highly specific monoclonal antibodies for A. ocellatum dinospores and develop a lateral flow-based rapid diagnostic test. The NOAA SBIR program...

Viva Viral Vaccines, Inc. received a $299,968 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 25, 2025, through August 31, 2026. The project is being conducted in Ithaca, New York. The award funds development of a broad-spectrum, multivalent vaccine platform targeting influenza neuraminidase (NA) protein that addresses critical limitations in current...

Federal Grant Award Summary Quornix, LLC received a $174,621 Phase I award from the Institute of Food Production and Sustainability under the Small Business Innovation Research (SBIR) Program (CFDA 10.212) to develop a therapeutic feed additive for treating vibriosis in shrimp aquaculture. The product is designed to function as a cost-effective prophylactic and responsive treatment, administered through feed to shrimp farmers. By reducing disease-related losses in shrimp production ponds, the...

The University of Florida's Division of Sponsored Research received a $650,000 Project Grant award from the Institute of Food Production and Sustainability under the Agriculture and Food Research Initiative (AFRI) Foundational and Applied Science Program (CFDA 10.310), effective March 1, 2026 through February 28, 2029. The award funds development of a needle-free, water-based vaccine delivered to fish through their aquatic environment rather than individual injections. The vaccine uses a...

Invvax, Inc. received a $996,606 Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) effective July 1, 2025, through June 30, 2027. The award supports a Small Business Innovation Research (SBIR) Phase II project focused on developing Stable Prophylactic Antibodies (SPABs) that maintain efficacy over extended periods. The primary deliverable is the creation of enhanced antibody mutations that significantly...

Federal Grant Award Summary Phycovax LLC received a $175,000 Project Grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) under the Small Business Innovation Research (SBIR) Program (CFDA 10.212), awarded September 1, 2025 with a completion date of April 30, 2027. The project focuses on developing an innovative feed-based vaccine to reduce Salmonella contamination in poultry. The solution leverages engineered diatoms—microscopic algae—that produce...

Federal Project Grant Award Summary Antigen Discovery Inc. (operating as Immport Therapeutics Inc.) received a $300,000 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 25, 2025, with completion targeted for July 31, 2027. The award supports development of a sensitive and specific serology-based potency test for whole cell pertussis (WP) vaccines to replace the outdated...